AbCellera Biologics Inc vs iShares Global Clean Energy ETF — how do they compare? AbCellera Biologics Inc trades at $8.99 (market cap $2.99B), while iShares Global Clean Energy ETF trades at $18.38. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| ABCL | ICLN | |
|---|---|---|
Market Cap | $2.99B | — |
Sector | Health | — |
52-Week High | $9.76 | $23.75 |
52-Week Low | $2.78 | $13.66 |
Enterprise Value | $2.58B | — |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →